Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples